#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar proteinosis X-linked lymphoproliferative syndrome Mantle cell lymphoma refractory Hepatic angiosarcoma Cardiac arrest Becker's muscular dystrophy Chronic granulomatous disease Ischaemic stroke Fatty acid oxidation disorder Primary adrenal insufficiency Inclusion body myositis Squamous cell carcinoma of head and neck Scedosporium infection Neuroendocrine tumour of the lung Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Pulmonary fibrosis – Diagnostics Choroid melanoma Pemphigus – Treatment Synovial sarcoma metastatic Basal cell naevus syndrome – Diagnostics Hairy cell leukaemia – Diagnostics Leiomyosarcoma recurrent – Treatment Congenital hypotransferrinaemia – Life with Disease Gaucher’s disease type III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    1,3-BUTYLENE GLYCOL Sodium Chloride Ph. Eur. Paxalisib Pitolisant TAZAROTENE Calcium Carbonate Daunorubicin Mps-106 Pasireotide VTX2735 SODIUM Dronedarone BW-20805 Bp1.7881A Vx-264 Olopatadine Hydrochloride Treprostinil Sodium Heparin Sodium Cabotegravir Avutometinib XELAFASLATIDE More therapies…

    Learn about Your Condition

    Breast cancer recurrent Adenocarcinoma Brain neoplasm Pruritus Anal abscess Ligament sprain Colorectal cancer metastatic Osteonecrosis of jaw Periarthritis Palpitations Urticaria chronic Hairy cell leukaemia recurrent Follicular lymphoma stage III Pyelonephritis Skin wrinkling More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cutaneous T-cell lymphoma refractory

  • A Study of PTX-100 for Patients with Cutaneous T-Cell Lymphoma That Has Returned or Did Not Respond to Previous Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma recurrent
    • Cutaneous T-cell lymphoma refractory
    France Italy
  • Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Mogamulizumab
    Denmark France Germany Greece Italy Spain
  • Study of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma refractory
    • Cutaneous T-cell lymphoma
    Investigated Drugs:
    • Linperlisib
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!